Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.
Internal Medicine - Japan
doi 10.2169/internalmedicine.33.517
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1994
Authors
Publisher
Japanese Society of Internal Medicine